Polymyalgia Rheumatica Clinical Trials in Basel
2 recruitingBasel, Switzerland
Showing 1–2 of 2 trials
Recruiting
Phase 3
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Polymyalgia Rheumatica
Novartis Pharmaceuticals288 enrolled115 locationsNCT06331312
Recruiting
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
University Hospital, Basel, Switzerland30 enrolled1 locationNCT05479448